NEWPORT NEWS, VA – Here’s a question for you… Is it possible to learn key scienc...
A University of Texas at Arlington researcher is working to increase the securit...
PLYMOUTH MEETING, PA [June 12, 2023] — New research in the June 2023 issue of JN...
New York, NY — Today Google announced the Google Cyber NYC Institutional Researc...
In a recently published manuscript, Howard Colman, MD, PhD, Jon M. Huntsman Pres...
New 3D bioprinting process involving the University of Huddersfield could save t...
In a world of continuously warmer temperatures, a growing consensus demands that...
“[…] we demonstrated the new acylfulvene compound LP-284 has anti-tumor activity...
As adoption of Continuous Glucose Monitoring (CGM) continues to increase, there ...
NEW ORLEANS, La. – Ochsner Health has named Jim Molloy as the organization’s nex...
Niigata, Japan – The gold standard test for predicting the onset of diabetic kid...
Niigata, Japan – The Department of Neurology at Niigata University has developed...
Uproleselan sodium is under clinical development by GlycoMimetics and currently ...
RT-002 is under clinical development by Revance Therapeutics and currently in Ph...
Pimitespib is under clinical development by Otsuka Pharmaceutical and currently ...
NuGel is under clinical development by Shaperon and currently in Phase I for Sep...
